Skip to main content
Guidance

Exporting active substances for medicines after Brexit

How the ‘Written Confirmation’ process for active substances manufactured in the UK will be handled if there’s a no-deal Brexit.

This publication was withdrawn on

For current information on Exporting active substances for medicines see Good manufacturing practice and good distribution practice

Documents

Details

This guidance explains how to obtain a Written Confirmation for each shipment of Active Substances manufactured in the UK that is exported to the EEA.

In a no-deal Brexit, we will continue to accept importation of active substances into the UK without a Written Confirmation from the same list of countries as currently (European Economic Area (EEA) countries, USA, Japan, Brazil, Australia, Israel and Switzerland).

Further guidance is available on importation of active substances from countries on a list.

Sign up for emails or print this page